Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.

Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnæs E, Rossing M, Specht L, Therkildsen MH, Nauntofte B, Dabelsteen S, von Buchwald C.

Br J Cancer. 2011 Mar 1;104(5):830-40. doi: 10.1038/bjc.2011.29. Epub 2011 Feb 15.

2.

MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen JA, Krogdahl A, Clark SJ, Kjems J.

PLoS One. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840. Epub 2011 Nov 22.

3.

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.

Cancer Res. 2008 Apr 1;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.

4.

MicroRNAs: small molecules with a potentially role in oral squamous cell carcinoma.

Gomes CC, de Sousa SF, Gomez RS.

Curr Pharm Des. 2013;19(7):1285-91. Review.

PMID:
23092348
5.

microRNA expression profiles in oral squamous cell carcinoma.

Soga D, Yoshiba S, Shiogama S, Miyazaki H, Kondo S, Shintani S.

Oncol Rep. 2013 Aug;30(2):579-83. doi: 10.3892/or.2013.2488. Epub 2013 May 23.

PMID:
23708842
6.

Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.

Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS.

J Dent Res. 2014 Jul;93(7 Suppl):86S-93S. doi: 10.1177/0022034514531018. Epub 2014 Apr 9.

7.

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.

Lajer CB, Garnæs E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, Specht L, Buchwald C, Nielsen FC.

Br J Cancer. 2012 Apr 24;106(9):1526-34. doi: 10.1038/bjc.2012.109.

8.

miRNA expression profiles of oral squamous cell carcinomas.

Gombos K, Horváth R, Szele E, Juhász K, Gocze K, Somlai K, Pajkos G, Ember I, Olasz L.

Anticancer Res. 2013 Apr;33(4):1511-7.

PMID:
23564792
9.

Alterations in miRNA expression patterns in whole blood of OSCC patients.

Ries J, Vairaktaris E, Kintopp R, Baran C, Neukam FW, Nkenke E.

In Vivo. 2014 Sep-Oct;28(5):851-61.

PMID:
25189899
10.

Integrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes.

Serrano NA, Xu C, Liu Y, Wang P, Fan W, Upton MP, Houck JR, Lohavanichbutr P, Kao M, Zhao LP, Schwartz SM, Chen C, Méndez E.

Otolaryngol Head Neck Surg. 2012 Sep;147(3):501-8. doi: 10.1177/0194599812442490. Epub 2012 Apr 2.

PMID:
22470160
11.

MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M, Carinci F.

Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1229-34.

PMID:
21244772
12.

Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.

Siow MY, Ng LP, Vincent-Chong VK, Jamaludin M, Abraham MT, Abdul Rahman ZA, Kallarakkal TG, Yang YH, Cheong SC, Zain RB.

Oral Dis. 2014 May;20(4):345-51. doi: 10.1111/odi.12118. Epub 2013 May 7.

PMID:
23651447
13.

miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.

Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW, Nkenke E.

Oncol Rep. 2014 Mar;31(3):1429-36. doi: 10.3892/or.2014.2983. Epub 2014 Jan 20.

PMID:
24452363
14.

MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.

Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR, Wu TS, Lin SK, Kuo MY, Tan CT.

Oral Oncol. 2013 Sep;49(9):923-31. doi: 10.1016/j.oraloncology.2013.03.430. Epub 2013 Apr 17.

PMID:
23602254
15.

Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma.

Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S, Hofele C.

J Oral Pathol Med. 2007 May;36(5):267-72.

PMID:
17448136
16.

Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.

Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, Yen YC, Jiang SS, Shieh YS, Chang IS, Hsiao M, Chang JY.

Cancer Res. 2014 Dec 15;74(24):7560-72. doi: 10.1158/0008-5472.CAN-14-0978. Epub 2014 Oct 28.

17.

Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.

Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

J Dermatol Sci. 2012 Dec;68(3):119-26. doi: 10.1016/j.jdermsci.2012.09.004. Epub 2012 Sep 13.

PMID:
23026055
18.

Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.

Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC.

Oncogene. 2012 May 10;31(19):2401-11. doi: 10.1038/onc.2011.423. Epub 2011 Sep 19. Erratum in: Oncogene. 2013 Jan 31;32(5):670.

PMID:
21927029
19.

Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.

Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP.

Genes Chromosomes Cancer. 2002 Jun;34(2):224-33.

PMID:
11979556
20.

MicroRNAs: new actors in the oral cancer scene.

Wu BH, Xiong XP, Jia J, Zhang WF.

Oral Oncol. 2011 May;47(5):314-9. doi: 10.1016/j.oraloncology.2011.03.019. Epub 2011 Apr 6. Review.

PMID:
21474366
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk